Dass-167 |link| (2026 Update)

In vivo studies have also demonstrated the efficacy of DASS-167 in mouse models of SARS-CoV-2 infection. Mice treated with DASS-167 showed a significant reduction in viral titers and lung inflammation compared to vehicle-treated controls. These findings suggest that DASS-167 has the potential to be developed as a therapeutic agent for the treatment of COVID-19.

Each subscale contains a range of items rated on a 4-point Likert scale, from 0 (did not apply to me at all) to 3 (applied to me very much, or most of the time). The scores for each subscale are calculated by summing the ratings for the respective items. DASS-167

Measures physiological arousal, fear responses, and situational anxiety. In vivo studies have also demonstrated the efficacy